An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access. (2022)
Attributed to:
UK Biobank (core renewal)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0272260
PubMed Identifier: 36067162
Publication URI: http://europepmc.org/abstract/MED/36067162
Type: Journal Article/Review
Volume: 17
Parent Publication: PloS one
Issue: 9
ISSN: 1932-6203